SINGAPORE – The temporary listing of etomidate as a Class C drug has been extended till April 30.
According to a legislative supplement published in the Government Gazette on Feb 26, the regulations relating to the anaesthetic agent etomidate and its variant, metomidate, will be extended for two months.
The drugs were listed under the Misuse of Drugs Act as a Class C drug from Sept 1, 2025, amid a surge in reports of young people using etomidate-laced vapes, also known as Kpods.
This allowed the authorities to introduce tougher penalties to deal with those who abuse and traffic etomidate.
The temporary provisions were previously slated to expire on Feb 28.
Coordinating Minister for National Security and Home Affairs Minister K. Shanmugam had said on Feb 4 that
etomidate would remain a Class C drug
